Profile data is unavailable for this security.
About the company
CellSeed Inc. is mainly engaged in the regenerative medical business. The Company operates in two business segments. The Regenerative Medical Support segment is engaged in the research, development, manufacture and sale of temperature-responsive cell incubators. The Cell Sheet Regeneration Medical segment is involved in the research and development of cell sheet regenerative medical products.
- Revenue in JPY (TTM)120.30m
- Net income in JPY-1.03bn
- Incorporated2001
- Employees38.00
- LocationCellSeed Inc15FTelecom Center East Bldg., 2-5-10, AomiKOTO-KU 135-0064JapanJPN
- Phone+81 363807490
- Fax+81 363807491
- Websitehttps://www.cellseed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kohjin Bio Co Ltd | 5.20bn | 719.61m | 6.27bn | 167.00 | 8.72 | 1.08 | 5.71 | 1.21 | 140.79 | 140.79 | 1,017.95 | 1,137.25 | 0.5995 | 3.69 | 5.53 | 31,156,770.00 | 8.29 | -- | 11.44 | -- | 44.58 | -- | 13.83 | -- | 1.61 | -- | 0.2512 | -- | 9.14 | -- | 106.44 | -- | -- | -- |
| MEDRx Co Ltd | 121.55m | -1.26bn | 6.71bn | 22.00 | -- | 3.12 | -- | 55.19 | -25.69 | -25.69 | 2.40 | 36.20 | 0.0494 | 0.0538 | 1.82 | 5,525,137.00 | -51.01 | -50.16 | -52.60 | -53.46 | 99.26 | 97.56 | -1,033.29 | -1,068.36 | 30.81 | -180.53 | 0.00 | -- | 773.28 | 8.71 | 13.52 | -- | -74.64 | -- |
| Nippon Chemiphar Co Ltd | 32.52bn | 545.00m | 7.46bn | 855.00 | 11.59 | 0.3296 | 3.64 | 0.2293 | 151.00 | 151.00 | 9,009.80 | 5,309.46 | 0.6233 | 1.98 | 2.75 | 38,035,090.00 | 1.04 | 0.6794 | 1.44 | 0.9686 | 26.19 | 28.43 | 1.68 | 1.04 | 1.34 | -- | 0.4785 | 55.16 | 5.93 | 0.5075 | 263.33 | -7.58 | 32.85 | 0.00 |
| K Pharma Inc | 0.00 | -993.23m | 7.95bn | 17.00 | -- | 6.28 | -- | -- | -85.59 | -85.59 | 0.00 | 109.00 | 0.00 | 0.00 | -- | -- | -37.53 | -- | -38.74 | -- | -- | -- | -- | -- | 28.29 | -1,982.81 | 0.5424 | -- | -- | -- | -17.34 | -- | -- | -- |
| CellSource Co Ltd | 3.71bn | 10.66m | 8.13bn | 148.00 | 819.44 | 1.35 | 38.91 | 2.19 | 0.5003 | 0.5003 | 186.84 | 303.58 | 0.5265 | 5.91 | 11.31 | 25,077,400.00 | 0.1512 | 10.68 | 0.1613 | 11.89 | 56.24 | 64.88 | 0.2872 | 14.37 | 11.79 | 16.09 | 0.0093 | 20.88 | -14.78 | 14.87 | -95.52 | -47.76 | 8.90 | -- |
| COSMO BIO COMPANY, LIMITED | 10.51bn | 243.00m | 8.15bn | 174.00 | 31.62 | 0.8244 | 20.43 | 0.7755 | 42.64 | 42.64 | 1,842.53 | 1,635.05 | 0.891 | 6.52 | 4.02 | 60,419,540.00 | 2.08 | 5.38 | 2.41 | 6.41 | 34.20 | 36.39 | 2.34 | 5.95 | 5.52 | -- | 0.002 | 41.03 | 7.46 | 5.75 | -40.72 | 2.03 | 8.68 | 28.99 |
| Solasia Pharma KK | 326.00m | -1.80bn | 8.35bn | 23.00 | -- | 4.48 | -- | 25.60 | -8.12 | -8.12 | 1.44 | 6.91 | 0.1383 | 0.5431 | 5.67 | 14,173,910.00 | -76.18 | -64.46 | -87.38 | -80.79 | 73.93 | 59.35 | -550.92 | -401.81 | 4.27 | -77.04 | 0.0547 | -- | -48.78 | -24.75 | -74.55 | -- | -73.26 | -- |
| CellSeed Inc | 120.30m | -1.03bn | 11.16bn | 38.00 | -- | 7.98 | -- | 92.80 | -29.71 | -29.71 | 3.47 | 37.83 | 0.0562 | 1.22 | 4.75 | 3,165,816.00 | -48.11 | -45.50 | -51.99 | -49.29 | 52.72 | 57.47 | -856.11 | -478.14 | 7.05 | -- | 0.0949 | -- | 1.65 | -6.87 | -1.57 | -- | 6.39 | -- |
| Wakamoto Pharmaceutical Co Ltd | 9.29bn | 298.60m | 11.29bn | 286.00 | 37.66 | 0.93 | 15.24 | 1.21 | 8.60 | 8.60 | 267.77 | 348.39 | 0.6006 | 1.62 | 3.06 | 32,493,160.00 | 1.93 | -0.0678 | 2.22 | -0.0781 | 47.70 | 48.65 | 3.21 | -0.1246 | 2.42 | -- | 0.0082 | -- | 0.6595 | -6.53 | -40.86 | -- | 21.87 | -- |
| Stella Pharma Corp | 991.86m | -180.01m | 12.39bn | 43.00 | -- | 4.27 | -- | 12.49 | -5.29 | -5.29 | 29.15 | 85.22 | 0.1958 | 0.1084 | 2.67 | 23,066,440.00 | -3.55 | -16.41 | -3.74 | -18.19 | 87.15 | 87.03 | -18.15 | -176.16 | 12.27 | -26.44 | 0.1917 | -- | 256.62 | -- | 81.56 | -- | -21.34 | -- |
| ReproCell Inc | 2.52bn | -324.61m | 15.26bn | 99.00 | -- | 1.73 | -- | 6.06 | -3.42 | -3.42 | 26.63 | 92.82 | 0.2328 | 4.15 | 5.92 | 25,450,770.00 | -3.00 | -4.09 | -3.63 | -4.47 | 49.35 | 43.75 | -12.88 | -13.66 | 4.93 | -- | 0.00 | -- | 22.74 | 19.94 | 428.65 | -- | -6.31 | -- |
| TAIKO PHARMACEUTICAL CO LTD | 5.94bn | 853.00m | 15.29bn | 214.00 | 17.78 | 1.84 | 13.75 | 2.57 | 16.99 | 16.99 | 118.31 | 163.90 | 0.475 | 1.43 | 2.95 | 27,766,360.00 | 6.82 | -- | 8.43 | -- | 55.74 | -- | 14.36 | -- | 2.68 | -- | 0.1105 | -- | 2.81 | -- | 124.87 | -- | -- | -- |
| Immuno-Biological Laboratories Co., Ltd. | 1.03bn | 363.89m | 16.10bn | 58.00 | 44.23 | 9.13 | 59.39 | 15.60 | 39.07 | 39.07 | 110.76 | 189.25 | 0.5456 | 0.8603 | 4.81 | 17,786,030.00 | 19.25 | -4.96 | 22.46 | -5.77 | 70.35 | 62.70 | 35.27 | -11.27 | 3.96 | 2,702.08 | 0.0947 | -- | 18.71 | 10.95 | 33.40 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to CellSeed Inc's reporting currency: Japanese Yen JPY
0.27%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Simplex Asset Management Co., Ltd.as of 08 Jan 2026 | 96.60k | 0.27% |
Data from 03 Feb 2026 - 03 Feb 2026Source: FactSet Research Systems Inc.
